About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,587 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,587 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3401-3420 of 6,587 trials

TerminatedPU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard TreatmentBackground: \- PU-H71 is an experimental drug used to treat cancer. It works by blocking a protein in tumors.NCT01581541·Bethesda, Maryland CompletedS0108 Bevacizumab in Treating Patients With Non-Hodgkin's LymphomaPhase II trial to study the effectiveness of bevacizumab in treating patients who have non-Hodgkin's lymphoma.NCT00016094·San Antonio, Texas TerminatedPilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesThis is a pilot study designed to evaluate the safety and feasibility of performing umbilical cord blood transplants in adults with high-risk hematopoietic malignancies.NCT00514722·San Francisco, California

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

Active not recruitingFirst-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell LymphomaThe purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritamab, an antibody also known as EPKINLY™…NCT03625037·Phoenix, Arizona and 84 others

CompletedA Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin LymphomaThe purpose of this study is to test the benefit of a chemotherapy drug called romidepsin in patients with T Cell Non-Hodgkin Lymphoma (T NHL) who have undergone autologous…NCT01908777·Tampa, Florida and 9 others

Active not recruitingFirst-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228This is the first-in-human study with BYON4228, a humanized monoclonal antibody (mAb) directed against SIRPα.NCT05737628·Brescia and 11 others

UnknownStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersRATIONALE: Giving chemotherapy, such as fludarabine, busulfan, and cyclophosphamide, together with antithymocyte globulin before a donor stem cell transplant helps stop the growth…NCT00740467·Marseille

CompletedCalaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaThis randomized clinical trial is studying giving calaspargase pegol together with combination chemotherapy to see how well it works compared with giving pegaspargase together…NCT00671034·Birmingham, Alabama and 26 others

CompletedPegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone LymphomaThis phase II trial studies the side effects and how well giving pegfilgrastim together with rituximab works in treating patients with untreated, relapsed, or refractory…NCT01682044·Buffalo, New York

Active not recruitingPhase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin LymphomaThis is a phase 1 study to evaluate safety and dose-limiting toxicity of autologous CD30.CAR-T in subjects with relapsed or refractory CD30+ Non-Hodgkin LymphomaNCT04526834·Duarte, California and 3 others

CompletedPreliminary Assessment of [18F]BL40 in PET/CT ScansCXCR4 is type of receptor that has been detected in more than twenty different subtypes of cancers.NCT06224309·Vancouver, British Columbia

CompletedStudy of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)The purpose of this study is to determine if MDX-1203 is safe for the treatment of renal cell carcinoma or non-hodgkin's lymphoma.NCT00944905·New Haven, Connecticut and 4 others

CompletedBulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell TransplantationThe purpose of this study is to find out if getting a blood stem cell transplant with donor stem cells given over several days is better than getting a blood stem cell transplant…NCT01596257·New York, New York

Active not recruitingALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin LymphomaThis phase I/II trial finds out the best dose, possible benefits and/or side effects of ALX148 in combination with rituximab and lenalidomide in treating patients with indolent…NCT05025800·Houston, Texas

UnknownMarginal Zone Lymphoma Cohort in KoreaMarginal zone lymphoma is a rare of subtype of Non-Hodgkin Lymphoma. Because of its rarity, prospective clinical trial is difficult to conduct.NCT02732236·Busan

Active not recruitingPembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.This phase I trial studies the side effects and best dose of vorinostat when given together with pembrolizumab in treating patients with diffuse large B-cell lymphoma, follicular…NCT03150329·Duarte, California

UnknownStudy of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaThis is a phase I study of BTK inhibitor CT-1530 in patients with relapsed or refractory B cell non-Hodgkin lymphoma (B-NHL), chronic lymphocytic leukemia (CLL) or Waldenstrom's…NCT02981745·Beijing, Beijing Municipality

Active not recruitingBAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALLA Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaNCT04690595·Duarte, California

TerminatedTrial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)Brief Summary: This study will test the safety, including side effects, and determine the characteristics of a drug called GEN1160 (PRO1160) in participants with solid tumors and…NCT05721222·Duarte, California and 16 others

CompletedApremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and EfficacyThis is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study designed to evaluate the efficacy and safety of apremilast (CC-10004) in subjects with mild to…NCT03721172·Birmingham, Alabama and 63 others

PreviousPage 171 of 330Next